Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Chicago Medical Center, Chicago, IL.
Section of Hematologic Oncology, Program for Supportive Oncology, Department of Medicine, University of Chicago Medical Center, Chicago, IL.
JCO Oncol Pract. 2020 Aug;16(8):483-489. doi: 10.1200/JOP.19.00710. Epub 2020 Apr 2.
Malignant bowel obstruction (MBO) from gynecologic cancer is associated with increased symptoms and short survival. A gynecologic oncologist's approach to palliative care consultation in the setting of MBO has not been well studied-it could be an opportune time for collaboration with palliative care.
This qualitative analysis of interviews with gynecologic oncologists focuses on their perspectives on palliative care consultation at the time of MBO. Interviews were analyzed using a framework analysis, and key themes and quotations were extracted.
We interviewed 15 gynecologic oncologists from 8 institutions in Chicago. They described a variety of expectations from palliative care consultation. Most frequently, they consulted palliative care for specific questions but managed the remainder of the care. Most participants frequently consulted palliative care, but they also worried about fragmentation of care, the timing of when to introduce a new team during MBO, and the selection of appropriate patients for a limited resource. Many participants preferred earlier palliative care consultation, and many described an emotional toll of caring for patients with MBO. Palliative care consultation was most readily discussed for nonsurgical patients.
Participants' expectations of palliative care consultations during MBO varied and were not always met. We recommend strengthening communication and protocols for palliative care involvement that meet the needs of specific patient populations and physician teams for surgical and nonsurgical patients. More research is needed to better understand how to integrate palliative care into oncologic and surgical care with gynecologic oncologists.
妇科癌症引起的恶性肠梗阻(MBO)与症状加重和生存时间缩短有关。妇科肿瘤学家在 MBO 情况下对姑息治疗咨询的方法尚未得到很好的研究 - 这可能是与姑息治疗合作的一个恰当时机。
本研究对来自芝加哥 8 家机构的 15 名妇科肿瘤学家进行了采访,重点分析了他们在 MBO 时对姑息治疗咨询的看法。使用框架分析对访谈进行分析,并提取了关键主题和引文。
我们采访了来自芝加哥 8 家机构的 15 名妇科肿瘤学家。他们描述了姑息治疗咨询的各种期望。最常见的是,他们咨询姑息治疗以获得具体问题的答案,但同时也管理其余的护理。大多数参与者经常咨询姑息治疗,但他们也担心护理的碎片化、在 MBO 期间何时引入新团队的时间以及为有限资源选择合适患者的问题。许多参与者更喜欢更早的姑息治疗咨询,许多人描述了照顾 MBO 患者的情感负担。姑息治疗咨询最容易在非手术患者中进行讨论。
参与者对 MBO 期间姑息治疗咨询的期望各不相同,且并不总是得到满足。我们建议加强姑息治疗的沟通和协议,以满足特定患者群体和外科医生团队对手术和非手术患者的需求。需要进一步研究以更好地了解如何将姑息治疗与妇科肿瘤学和外科护理相结合。